| F1Y | Name: | N-hydroxy-4-[(2-propylimidazo[1,2-a]pyridin-3-yl)amino]benzamide | Formula: | C17 H18 N4 O2 | SMILES: | c3(ccc(Nc2c(CCC)nc1ccccn12)cc3)C(=O)NO | InChi: | InChI=1S/C17H18N4O2/c1-2-5-14-16(21-11-4-3-6-15(21)19-14)18-13-9-7-12(8-10-13)17(22)20-23/h3-4,6-11,18,23H,2,5H2,1H3,(H,20,22) | Definition date: | 2018-02-23 | Last modified: | 2018-06-08 | Release date: | 2018-06-13 | Identifier: | N-hydroxy-4-[(2-propylimidazo[1,2-a]pyridin-3-yl)amino]benzamide |
|
| EQG | Name: | benzyl [(6S,7S,10S,13S,18Z)-18-amino-10-cyclohexyl-6-hydroxy-18-imino-7-(2-methylpropyl)-4,9,12-trioxo-1-phenyl-16-oxa-3,8,11,17-tetraazaoctadecan-13-yl]carbamate | Formula: | C37 H55 N7 O7 | SMILES: | C(NC(CCON/C(N)=N)C(NC(C(NC(C(O)CC(NCCc1ccccc1)=O)CC(C)C)=O)C2CCCCC2)=O)(OCc3ccccc3)=O | InChi: | InChI=1S/C37H55N7O7/c1-25(2)22-30(31(45)23-32(46)40-20-18-26-12-6-3-7-13-26)41-35(48)33(28-16-10-5-11-17-28)43-34(47)29(19-21-51-44-36(38)39)42-37(49)50-24-27-14-8-4-9-15-27/h3-4,6-9,12-15,25,28-31,33,45H,5,10-11,16-24H2,1-2H3,(H,40,46)(H,41,48)(H,42,49)(H,43,47)(H4,38,39,44)/t29-,30-,31-,33-/m0/s1 | Definition date: | 2018-01-26 | Last modified: | 2018-06-08 | Release date: | 2018-06-13 | Identifier: | benzyl [(6S,7S,10S,13S,18Z)-18-amino-10-cyclohexyl-6-hydroxy-18-imino-7-(2-methylpropyl)-4,9,12-trioxo-1-phenyl-16-oxa-3,8,11,17-tetraazaoctadecan-13-yl]carbamate |
|
| 81J | Name: | 4-ethoxybenzoic acid | Formula: | C9 H10 O3 | SMILES: | C(O)(c1ccc(OCC)cc1)=O | InChi: | InChI=1S/C9H10O3/c1-2-12-8-5-3-7(4-6-8)9(10)11/h3-6H,2H2,1H3,(H,10,11) | Definition date: | 2016-12-14 | Last modified: | 2018-06-08 | Release date: | 2018-06-13 | Identifier: | 4-ethoxybenzoic acid |
|
| 81M | Name: | 4-(ethylsulfanyl)benzoic acid | Formula: | C9 H10 O2 S | SMILES: | C(O)(c1ccc(SCC)cc1)=O | InChi: | InChI=1S/C9H10O2S/c1-2-12-8-5-3-7(4-6-8)9(10)11/h3-6H,2H2,1H3,(H,10,11) | Definition date: | 2016-12-14 | Last modified: | 2018-06-08 | Release date: | 2018-06-13 | Identifier: | 4-(ethylsulfanyl)benzoic acid |
|
| 9EE | Name: | adipamide | Formula: | C6 H12 N2 O2 | SMILES: | NC(=O)CCCCC(N)=O | InChi: | InChI=1S/C6H12N2O2/c7-5(9)3-1-2-4-6(8)10/h1-4H2,(H2,7,9)(H2,8,10) | Definition date: | 2017-05-11 | Last modified: | 2018-06-08 | Release date: | 2018-06-13 | Identifier: | hexanediamide |
|
| 9KT | Name: | 1,4-dimethylquinoxaline-2,3-dione | Formula: | C10 H10 N2 O2 | SMILES: | CN1C(=O)C(=O)N(C)c2ccccc12 | InChi: | InChI=1S/C10H10N2O2/c1-11-7-5-3-4-6-8(7)12(2)10(14)9(11)13/h3-6H,1-2H3 | Definition date: | 2017-05-31 | Last modified: | 2018-06-08 | Release date: | 2018-06-13 | Identifier: | 1,4-dimethylquinoxaline-2,3-dione |
|
| 9KW | Name: | ~{N}-[1,4-dimethyl-7-morpholin-4-yl-2,3-bis(oxidanylidene)quinoxalin-6-yl]-5,6,7,8-tetrahydronaphthalene-2-sulfonamide | Formula: | C24 H28 N4 O5 S | SMILES: | CN1C(=O)C(=O)N(C)c2cc(N3CCOCC3)c(N[S](=O)(=O)c4ccc5CCCCc5c4)cc12 | InChi: | InChI=1S/C24H28N4O5S/c1-26-21-14-19(25-34(31,32)18-8-7-16-5-3-4-6-17(16)13-18)20(28-9-11-33-12-10-28)15-22(21)27(2)24(30)23(26)29/h7-8,13-15,25H,3-6,9-12H2,1-2H3 | Definition date: | 2017-05-31 | Last modified: | 2018-06-08 | Release date: | 2018-06-13 | Identifier: | ~{N}-[1,4-dimethyl-7-morpholin-4-yl-2,3-bis(oxidanylidene)quinoxalin-6-yl]-5,6,7,8-tetrahydronaphthalene-2-sulfonamide |
|
| 9L5 | Name: | ~{N}-[(1~{S})-1-(1,5-dimethylpyrazol-4-yl)ethyl]-1-ethyl-3-methyl-2-oxidanylidene-quinoxaline-6-carboxamide | Formula: | C19 H23 N5 O2 | SMILES: | CCN1C(=O)C(=Nc2cc(ccc12)C(=O)N[CH](C)c3cnn(C)c3C)C | InChi: | InChI=1S/C19H23N5O2/c1-6-24-17-8-7-14(9-16(17)21-12(3)19(24)26)18(25)22-11(2)15-10-20-23(5)13(15)4/h7-11H,6H2,1-5H3,(H,22,25)/t11-/m0/s1 | Definition date: | 2017-06-01 | Last modified: | 2018-06-08 | Release date: | 2018-06-13 | Identifier: | ~{N}-[(1~{S})-1-(1,5-dimethylpyrazol-4-yl)ethyl]-1-ethyl-3-methyl-2-oxidanylidene-quinoxaline-6-carboxamide |
|
| 9LK | Name: | ~{N}-[6-(4-chloranylphenoxy)pyridin-3-yl]-2,4-dimethyl-1,3-oxazole-5-carboxamide | Formula: | C17 H14 Cl N3 O3 | SMILES: | Cc1oc(c(C)n1)C(=O)Nc2ccc(Oc3ccc(Cl)cc3)nc2 | InChi: | InChI=1S/C17H14ClN3O3/c1-10-16(23-11(2)20-10)17(22)21-13-5-8-15(19-9-13)24-14-6-3-12(18)4-7-14/h3-9H,1-2H3,(H,21,22) | Definition date: | 2017-06-02 | Last modified: | 2018-06-08 | Release date: | 2018-06-13 | Identifier: | ~{N}-[6-(4-chloranylphenoxy)pyridin-3-yl]-2,4-dimethyl-1,3-oxazole-5-carboxamide |
|
| 9LN | Name: | 1-ethyl-~{N}-methyl-2,3-bis(oxidanylidene)-~{N}-[(1-phenylpyrazol-4-yl)methyl]-4~{H}-quinoxaline-6-carboxamide | Formula: | C22 H21 N5 O3 | SMILES: | CCN1C(=O)C(=O)Nc2cc(ccc12)C(=O)N(C)Cc3cnn(c3)c4ccccc4 | InChi: | InChI=1S/C22H21N5O3/c1-3-26-19-10-9-16(11-18(19)24-20(28)22(26)30)21(29)25(2)13-15-12-23-27(14-15)17-7-5-4-6-8-17/h4-12,14H,3,13H2,1-2H3,(H,24,28) | Definition date: | 2017-06-02 | Last modified: | 2018-06-08 | Release date: | 2018-06-13 | Identifier: | 1-ethyl-~{N}-methyl-2,3-bis(oxidanylidene)-~{N}-[(1-phenylpyrazol-4-yl)methyl]-4~{H}-quinoxaline-6-carboxamide |
|
| 9LT | Name: | 1-ethyl-~{N}-[(~{R})-(3-fluorophenyl)-(1-methylimidazol-2-yl)methyl]-2,3-bis(oxidanylidene)-4~{H}-quinoxaline-6-carboxamide | Formula: | C22 H20 F N5 O3 | SMILES: | CCN1C(=O)C(=O)Nc2cc(ccc12)C(=O)N[CH](c3cccc(F)c3)c4nccn4C | InChi: | InChI=1S/C22H20FN5O3/c1-3-28-17-8-7-14(12-16(17)25-21(30)22(28)31)20(29)26-18(19-24-9-10-27(19)2)13-5-4-6-15(23)11-13/h4-12,18H,3H2,1-2H3,(H,25,30)(H,26,29)/t18-/m1/s1 | Definition date: | 2017-06-02 | Last modified: | 2018-06-08 | Release date: | 2018-06-13 | Identifier: | 1-ethyl-~{N}-[(~{R})-(3-fluorophenyl)-(1-methylimidazol-2-yl)methyl]-2,3-bis(oxidanylidene)-4~{H}-quinoxaline-6-carboxamide |
|
| 9LZ | Name: | (2~{S})-2-[[(2~{S})-6-[[(2~{S})-2-[[4-[[[(2~{S})-2-[[(2~{R})-2-[(6-fluoranylpyridin-3-yl)carbonylamino]-3-sulfo-propanoyl]amino]-3-sulfo-propanoyl]amino]methyl]phenyl]carbonylamino]-3-naphthalen-2-yl-propanoyl]amino]-1-oxidanyl-1-oxidanylidene-hexan-2-yl]carbamoylamino]pentanedioic acid | Formula: | C45 H51 F N8 O18 S2 | SMILES: | OC(=O)CC[CH](NC(=O)N[CH](CCCCNC(=O)[CH](Cc1ccc2ccccc2c1)NC(=O)c3ccc(CNC(=O)[CH](C[S](O)(=O)=O)NC(=O)[CH](C[S](O)(=O)=O)NC(=O)c4ccc(F)nc4)cc3)C(O)=O)C(O)=O | InChi: | InChI=1S/C45H51FN8O18S2/c46-36-16-14-30(22-48-36)39(58)51-35(24-74(70,71)72)42(61)52-34(23-73(67,68)69)41(60)49-21-25-8-12-28(13-9-25)38(57)50-33(20-26-10-11-27-5-1-2-6-29(27)19-26)40(59)47-18-4-3-7-31(43(62)63)53-45(66)54-32(44(64)65)15-17-37(55)56/h1-2,5-6,8-14,16,19,22,31-35H,3-4,7,15,17-18,20-21,23-24H2,(H,47,59)(H,49,60)(H,50,57)(H,51,58)(H,52,61)(H,55,56)(H,62,63)(H,64,65)(H2,53,54,66)(H,67,68,69)(H,70,71,72)/t31-,32-,33-,34+,35-/m0/s1 | Definition date: | 2017-06-02 | Last modified: | 2018-06-08 | Release date: | 2018-06-13 | Identifier: | (2~{S})-2-[[(2~{S})-6-[[(2~{S})-2-[[4-[[[(2~{S})-2-[[(2~{R})-2-[(6-fluoranylpyridin-3-yl)carbonylamino]-3-sulfo-propanoyl]amino]-3-sulfo-propanoyl]amino]methyl]phenyl]carbonylamino]-3-naphthalen-2-yl-propanoyl]amino]-1-oxidanyl-1-oxidanylidene-hexan-2-yl]carbamoylamino]pentanedioic acid |
|
| 9OQ | Name: | (2~{S})-2-[[(2~{S})-6-[[(2~{S})-2-[[4-[[[(2~{R})-2-[[(2~{R})-2-[(6-fluoranylpyridin-3-yl)carbonylamino]-5-oxidanyl-5-oxidanylidene-pentanoyl]amino]-5-oxidanyl-5-oxidanylidene-pentanoyl]amino]methyl]phenyl]carbonylamino]-3-naphthalen-2-yl-propanoyl]amino]-1-oxidanyl-1-oxidanylidene-hexan-2-yl]carbamoylamino]pentanedioic acid | Formula: | C49 H55 F N8 O16 | SMILES: | OC(=O)CC[CH](NC(=O)N[CH](CCCCNC(=O)[CH](Cc1ccc2ccccc2c1)NC(=O)c3ccc(CNC(=O)[CH](CCC(O)=O)NC(=O)[CH](CCC(O)=O)NC(=O)c4ccc(F)nc4)cc3)C(O)=O)C(O)=O | InChi: | InChI=1S/C49H55FN8O16/c50-38-18-14-32(26-52-38)43(66)54-34(16-20-40(61)62)46(69)55-33(15-19-39(59)60)44(67)53-25-27-8-12-30(13-9-27)42(65)56-37(24-28-10-11-29-5-1-2-6-31(29)23-28)45(68)51-22-4-3-7-35(47(70)71)57-49(74)58-36(48(72)73)17-21-41(63)64/h1-2,5-6,8-14,18,23,26,33-37H,3-4,7,15-17,19-22,24-25H2,(H,51,68)(H,53,67)(H,54,66)(H,55,69)(H,56,65)(H,59,60)(H,61,62)(H,63,64)(H,70,71)(H,72,73)(H2,57,58,74)/t33-,34-,35+,36+,37+/m1/s1 | Definition date: | 2017-06-19 | Last modified: | 2018-06-08 | Release date: | 2018-06-13 | Identifier: | (2~{S})-2-[[(2~{S})-6-[[(2~{S})-2-[[4-[[[(2~{R})-2-[[(2~{R})-2-[(6-fluoranylpyridin-3-yl)carbonylamino]-5-oxidanyl-5-oxidanylidene-pentanoyl]amino]-5-oxidanyl-5-oxidanylidene-pentanoyl]amino]methyl]phenyl]carbonylamino]-3-naphthalen-2-yl-propanoyl]amino]-1-oxidanyl-1-oxidanylidene-hexan-2-yl]carbamoylamino]pentanedioic acid |
|
| 9OT | Name: | (2~{S})-2-[[(2~{S})-6-[[(2~{S})-2-[[4-[[[(2~{S})-2-[[(2~{S})-2-[(6-fluoranylpyridin-3-yl)carbonylamino]-5-oxidanyl-5-oxidanylidene-pentanoyl]amino]-5-oxidanyl-5-oxidanylidene-pentanoyl]amino]methyl]phenyl]carbonylamino]-3-naphthalen-2-yl-propanoyl]amino]-1-oxidanyl-1-oxidanylidene-hexan-2-yl]carbamoylamino]pentanedioic acid | Formula: | C49 H55 F N8 O16 | SMILES: | OC(=O)CC[CH](NC(=O)N[CH](CCCCNC(=O)[CH](Cc1ccc2ccccc2c1)NC(=O)c3ccc(CNC(=O)[CH](CCC(O)=O)NC(=O)[CH](CCC(O)=O)NC(=O)c4ccc(F)nc4)cc3)C(O)=O)C(O)=O | InChi: | InChI=1S/C49H55FN8O16/c50-38-18-14-32(26-52-38)43(66)54-34(16-20-40(61)62)46(69)55-33(15-19-39(59)60)44(67)53-25-27-8-12-30(13-9-27)42(65)56-37(24-28-10-11-29-5-1-2-6-31(29)23-28)45(68)51-22-4-3-7-35(47(70)71)57-49(74)58-36(48(72)73)17-21-41(63)64/h1-2,5-6,8-14,18,23,26,33-37H,3-4,7,15-17,19-22,24-25H2,(H,51,68)(H,53,67)(H,54,66)(H,55,69)(H,56,65)(H,59,60)(H,61,62)(H,63,64)(H,70,71)(H,72,73)(H2,57,58,74)/t33-,34-,35-,36-,37-/m0/s1 | Definition date: | 2017-06-19 | Last modified: | 2018-06-08 | Release date: | 2018-06-13 | Identifier: | (2~{S})-2-[[(2~{S})-6-[[(2~{S})-2-[[4-[[[(2~{S})-2-[[(2~{S})-2-[(6-fluoranylpyridin-3-yl)carbonylamino]-5-oxidanyl-5-oxidanylidene-pentanoyl]amino]-5-oxidanyl-5-oxidanylidene-pentanoyl]amino]methyl]phenyl]carbonylamino]-3-naphthalen-2-yl-propanoyl]amino]-1-oxidanyl-1-oxidanylidene-hexan-2-yl]carbamoylamino]pentanedioic acid |
|
| 9WY | Name: | 1-deoxy-1-(7,8-dimethyl-2,4-dioxo-3,4-dihydrobenzo[g]pteridin-10(2H)-yl)-3-O-phosphono-D-ribitol | Formula: | C17 H21 N4 O9 P | SMILES: | C1=3C(=Nc2c(N1CC(C(C(CO)O)OP(O)(O)=O)O)cc(c(C)c2)C)C(=O)NC(N=3)=O | InChi: | InChI=1S/C17H21N4O9P/c1-7-3-9-10(4-8(7)2)21(15-13(18-9)16(25)20-17(26)19-15)5-11(23)14(12(24)6-22)30-31(27,28)29/h3-4,11-12,14,22-24H,5-6H2,1-2H3,(H,20,25,26)(H2,27,28,29)/t11?,12-,14+/m1/s1 | Definition date: | 2017-06-20 | Last modified: | 2018-06-08 | Release date: | 2018-06-13 | Identifier: | 1-deoxy-1-(7,8-dimethyl-2,4-dioxo-3,4-dihydrobenzo[g]pteridin-10(2H)-yl)-3-O-phosphono-D-ribitol |
|
| 9ZK | Name: | (4~{R},7~{R},10~{S},13~{S},15~{E},19~{S})-10-(4-azanylbutyl)-4-(4-hydroxyphenyl)-7-(1~{H}-indol-3-ylmethyl)-8,13,15,19-tetramethyl-1-oxa-5,8,11-triazacyclononadec-15-ene-2,6,9,12-tetrone | Formula: | C38 H51 N5 O6 | SMILES: | C[CH]1CCC=C(C)C[CH](C)C(=O)N[CH](CCCCN)C(=O)N(C)[CH](Cc2c[nH]c3ccccc23)C(=O)N[CH](CC(=O)O1)c4ccc(O)cc4 | InChi: | InChI=1S/C38H51N5O6/c1-24-10-9-11-26(3)49-35(45)22-33(27-15-17-29(44)18-16-27)42-37(47)34(21-28-23-40-31-13-6-5-12-30(28)31)43(4)38(48)32(14-7-8-19-39)41-36(46)25(2)20-24/h5-6,10,12-13,15-18,23,25-26,32-34,40,44H,7-9,11,14,19-22,39H2,1-4H3,(H,41,46)(H,42,47)/b24-10+/t25-,26-,32-,33+,34+/m0/s1 | Definition date: | 2017-08-07 | Last modified: | 2018-06-08 | Release date: | 2018-06-13 | Identifier: | (4~{R},7~{R},10~{S},13~{S},15~{E},19~{S})-10-(4-azanylbutyl)-4-(4-hydroxyphenyl)-7-(1~{H}-indol-3-ylmethyl)-8,13,15,19-tetramethyl-1-oxa-5,8,11-triazacyclononadec-15-ene-2,6,9,12-tetrone |
|
| AVO | Name: | Pyrrolidinohistidine | Formula: | C10 H17 N3 O2 | SMILES: | OC(=O)[CH](Cc1[nH]c[nH+]c1)[NH+]2CCCC2 | InChi: | InChI=1S/C10H15N3O2/c14-10(15)9(13-3-1-2-4-13)5-8-6-11-7-12-8/h6-7,9H,1-5H2,(H,11,12)(H,14,15)/p+2/t9-/m0/s1 | Definition date: | 2018-02-05 | Last modified: | 2018-06-08 | Release date: | 2018-06-13 | Identifier: | (2~{S})-3-(1~{H}-imidazol-3-ium-5-yl)-2-pyrrolidin-1-ium-1-yl-propanoic acid |
|
| 7L9 | Name: | 4-(3-carboxyphenyl)pyridine-2,5-dicarboxylic acid | Formula: | C14 H9 N O6 | SMILES: | O=C(O)c1cccc(c1)c2c(cnc(c2)C(O)=O)C(=O)O | InChi: | InChI=1S/C14H9NO6/c16-12(17)8-3-1-2-7(4-8)9-5-11(14(20)21)15-6-10(9)13(18)19/h1-6H,(H,16,17)(H,18,19)(H,20,21) | Definition date: | 2016-11-09 | Last modified: | 2018-06-08 | Release date: | 2018-06-13 | Identifier: | 4-(3-carboxyphenyl)pyridine-2,5-dicarboxylic acid |
|
| LU0 | Name: | Sulphamoil Leucine | Formula: | C6 H14 N2 O4 S | SMILES: | CC(C)C[CH](N[S](N)(=O)=O)C(O)=O | InChi: | InChI=1S/C6H14N2O4S/c1-4(2)3-5(6(9)10)8-13(7,11)12/h4-5,8H,3H2,1-2H3,(H,9,10)(H2,7,11,12)/t5-/m0/s1 | Definition date: | 2017-12-07 | Last modified: | 2018-06-08 | Release date: | 2018-06-13 | Identifier: | (2~{S})-4-methyl-2-(sulfamoylamino)pentanoic acid |
|
| DY8 | Name: | Morpholinohistidine | Formula: | C10 H17 N3 O3 | SMILES: | OC(=O)[CH](Cc1[nH]c[nH+]c1)[NH+]2CCOCC2 | InChi: | InChI=1S/C10H15N3O3/c14-10(15)9(5-8-6-11-7-12-8)13-1-3-16-4-2-13/h6-7,9H,1-5H2,(H,11,12)(H,14,15)/p+2/t9-/m0/s1 | Definition date: | 2018-02-05 | Last modified: | 2018-06-08 | Release date: | 2018-06-13 | Identifier: | (2~{S})-3-(1~{H}-imidazol-3-ium-5-yl)-2-morpholin-4-ium-4-yl-propanoic acid |
|
| DYT | Name: | (2~{S})-2-chloranyl-3-(1~{H}-imidazol-5-yl)propanoic acid | Formula: | C6 H7 Cl N2 O2 | SMILES: | OC(=O)[CH](Cl)Cc1[nH]cnc1 | InChi: | InChI=1S/C6H7ClN2O2/c7-5(6(10)11)1-4-2-8-3-9-4/h2-3,5H,1H2,(H,8,9)(H,10,11)/t5-/m0/s1 | Definition date: | 2018-02-05 | Last modified: | 2018-06-08 | Release date: | 2018-06-13 | Identifier: | (2~{S})-2-chloranyl-3-(1~{H}-imidazol-5-yl)propanoic acid |
|
| E0D | Name: | (3S)-1-[2-(3-ethanoylindol-1-yl)ethanoyl]piperidine-3-carboxylic acid | Formula: | C18 H20 N2 O4 | SMILES: | CC(=O)c1cn(CC(=O)N2CCC[CH](C2)C(O)=O)c3ccccc13 | InChi: | InChI=1S/C18H20N2O4/c1-12(21)15-10-20(16-7-3-2-6-14(15)16)11-17(22)19-8-4-5-13(9-19)18(23)24/h2-3,6-7,10,13H,4-5,8-9,11H2,1H3,(H,23,24)/t13-/m0/s1 | Definition date: | 2017-07-07 | Last modified: | 2018-06-08 | Release date: | 2018-06-13 | Identifier: | (3~{S})-1-[2-(3-ethanoylindol-1-yl)ethanoyl]piperidine-3-carboxylic acid |
|
| 8JL | Name: | 4-fluoranyl-3-[(4-methoxynaphthalen-1-yl)sulfonylamino]benzoic acid | Formula: | C18 H14 F N O5 S | SMILES: | COc1ccc(c2ccccc12)[S](=O)(=O)Nc3cc(ccc3F)C(O)=O | InChi: | InChI=1S/C18H14FNO5S/c1-25-16-8-9-17(13-5-3-2-4-12(13)16)26(23,24)20-15-10-11(18(21)22)6-7-14(15)19/h2-10,20H,1H3,(H,21,22) | Definition date: | 2017-07-19 | Last modified: | 2018-06-01 | Release date: | 2018-06-06 | Identifier: | 4-fluoranyl-3-[(4-methoxynaphthalen-1-yl)sulfonylamino]benzoic acid |
|
| 8JO | Name: | 2-fluoranyl-5-[(4-methoxynaphthalen-1-yl)sulfonylamino]benzoic acid | Formula: | C18 H14 F N O5 S | SMILES: | COc1ccc(c2ccccc12)[S](=O)(=O)Nc3ccc(F)c(c3)C(O)=O | InChi: | InChI=1S/C18H14FNO5S/c1-25-16-8-9-17(13-5-3-2-4-12(13)16)26(23,24)20-11-6-7-15(19)14(10-11)18(21)22/h2-10,20H,1H3,(H,21,22) | Definition date: | 2017-07-19 | Last modified: | 2018-06-01 | Release date: | 2018-06-06 | Identifier: | 2-fluoranyl-5-[(4-methoxynaphthalen-1-yl)sulfonylamino]benzoic acid |
|
| 8JR | Name: | 2-fluoranyl-3-[(4-methoxynaphthalen-1-yl)sulfonylamino]benzoic acid | Formula: | C18 H14 F N O5 S | SMILES: | COc1ccc(c2ccccc12)[S](=O)(=O)Nc3cccc(C(O)=O)c3F | InChi: | InChI=1S/C18H14FNO5S/c1-25-15-9-10-16(12-6-3-2-5-11(12)15)26(23,24)20-14-8-4-7-13(17(14)19)18(21)22/h2-10,20H,1H3,(H,21,22) | Definition date: | 2017-07-20 | Last modified: | 2018-06-01 | Release date: | 2018-06-06 | Identifier: | 2-fluoranyl-3-[(4-methoxynaphthalen-1-yl)sulfonylamino]benzoic acid |
|